Skip to main content
SpringerLink
Log in

Epidemiology and consequences of sarcopenia

  • Published:
JNHA - The Journal of Nutrition, Health and Aging

Abstract

Sarcopenia is an evolving concept and the current definition of sarcopenia includes both a loss of muscle strength and loss of muscle mass. However, despite the increasing knowledge and improved technology, a worldwide operational definition of sarcopenia applicable across racial/ethnic groups and populations lacks consensus. As a result the prevalence of sarcopenia (8 to 40% of older people over 60 years) varies depending on the study sample (namely the age of the sample), the definition, and the assessment tool used. DXA is the main assessment method used to evaluate muscle mass, which is further adjusted to height, weight fat mass, or BMI to obtain an index of sarcopenia. Cross-sectional analyses seemed to prove an association between low muscle mass and functional decline, but these results were not consistent when analysed longitudinally over time. This inconsistency could be due to methodological issues as the selected populations in the cohorts where autonomous, community-dwelling, older people. In this highly active population decreases in muscle mass might be not as important as decreases in strength to predict functional decline. The aim of the present paper was to perform a comprehensive review of the literature on the epidemiology of sarcopenia and its consequences to be presented on November 13th and 14th 2008, at the Carla Workshop.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Article 02 February 2017

Emanuele Marzetti, Riccardo Calvani, … on behalf of the SPRINTT Consortium

References

  1. Landi, F., et al., Body mass index and mortality among older people living in the community. J Am Geriatr Soc. 1999;47(9):1072–1076

    CAS  PubMed  Google Scholar 

  2. Rosenberg IH, Summary comments. Am J Clin Nutr. 1989;50:1231–1233

    Google Scholar 

  3. Adamo ML, Farrar RP. Resistance training and IGF involvement in the maintenance of muscle mass during the aging process. Ageing Res Rev. 2006;5:310–331

    Article  CAS  PubMed  Google Scholar 

  4. National Institutes of Health. Exercise: a guide from the national Institute on Aging. U.S. Department of Health and Human Services. 2004;34

  5. Schwartz, R.S., Sarcopenia and physical performance in old age: introduction. Muscle Nerve Suppl. 1997;5:S10–S12

    Article  CAS  PubMed  Google Scholar 

  6. Hughes VA, Frontera WR, Roubenhoff R, et al., Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76(2):473–481

    CAS  PubMed  Google Scholar 

  7. Vandervoort, A.A., Aging of the human neuromuscular system. Muscle Nerve. 2002;25(1):17–25

    Article  CAS  PubMed  Google Scholar 

  8. Roubenoff, R. and V.A. Hughes, Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci. 2000;55(12):M716–M772

    CAS  PubMed  Google Scholar 

  9. Morley, J.E., et al., Sarcopenia. J Lab Clin Med, 2001;137(4):231–243

    Article  CAS  PubMed  Google Scholar 

  10. Evans, W., Functional and metabolic consequences of sarcopenia. J Nutr. 1997;127(5 Suppl):998S–1003S

    CAS  PubMed  Google Scholar 

  11. Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci. 2001;56A:209–217

    Google Scholar 

  12. Gallagher, D., et al., Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 1997;83(1):229–239

    CAS  PubMed  Google Scholar 

  13. Janssen I, Shepard DS, Katzmarzyk PT, Roubenhoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–85

    Article  PubMed  Google Scholar 

  14. Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc. 2008;9(2):71–72

    Article  PubMed  Google Scholar 

  15. Abellan van Kan G, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging. 2008;12(1):29–37

    Article  CAS  PubMed  Google Scholar 

  16. Clark BC, Manini TM. Sarcopenia Dynapenia. J Gerontol A Biol Sci Med Sci. 2008;63(8):829–834

    PubMed  Google Scholar 

  17. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors on incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005;60:324–333

    PubMed  Google Scholar 

  18. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass is associated with mortality in the Health, Aging and Body Composition Study Cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72–77

    PubMed  Google Scholar 

  19. Rolland Y, Czerwinski S, Abellan van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12(7):433–450

    Article  CAS  PubMed  Google Scholar 

  20. Baumgartner RN, W.D., Sarcopenia and sarcopenic-obesity. Pathy MSJ ed. Principles and Practice of Geriatric Medicine. Vol. 2. 2006, United Kingdom: John Wiley and Sons Ltd. 909–933

    Google Scholar 

  21. Baumgartner RN, Koelher KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763

    CAS  PubMed  Google Scholar 

  22. Janssen I, Heymsfield SB, and Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–896

    Article  PubMed  Google Scholar 

  23. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54:56–62

    Article  PubMed  Google Scholar 

  24. Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51:1602–1609

    Article  PubMed  Google Scholar 

  25. Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–774

    Article  PubMed  Google Scholar 

  26. Melton LJ, Khosla S, Crowson CS, et al. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000;48:625–630

    PubMed  Google Scholar 

  27. Estrada M, Kleppinger A, Judge JO, et al. Functional impact of relative versus absolute sarcopenia in healthy older women. J Am Geriatr Soc. 2007;55:1712–1719

    Article  PubMed  Google Scholar 

  28. Iannuzzi-Sucich M, Prestwood KM, and Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57:772–777

    Google Scholar 

  29. Rolland Y, Lauwers-Cances V, Cournot M, et al. Sarcopenia, calf circumference, and physical function of elderly woman: a cross-sectional study. J Am Geriatr Soc. 2003;51:1120–1124

    Article  PubMed  Google Scholar 

  30. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. Body composition in French women 75+ years of age: the EPIDOS study. Mech Ageing Dev. 2003;124(3):311–316

    Article  Google Scholar 

  31. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–1860

    PubMed  Google Scholar 

  32. Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006;83:1142–1148

    CAS  PubMed  Google Scholar 

  33. Visser M, Deeg DJH, and Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766–5772

    Article  CAS  PubMed  Google Scholar 

  34. Kyle UG, Genton L, Hans D, et al. Total body mass, fat mass, fat-free mass, and skeletal muscle in older people: cross-sectional differences in 60-year-old persons. J Am Geriatr Soc. 2001;49:1633–1640

    Article  CAS  PubMed  Google Scholar 

  35. Lau EMC, Lynn HSH, Woo JW, et al. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci. 2005;60:213–216

    PubMed  Google Scholar 

  36. Visser M, Newman AB, Nevitt MC et al. Reexamining the sarcopenia hypothesis. Muscle mass versus muscle strength. Ann N Acad Sci. 2000; 904:456–461

    Article  CAS  Google Scholar 

  37. Visser M, Deeg DJ; Lips P, et al. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc. 2000;48(4):381–386

    CAS  PubMed  Google Scholar 

  38. Newman AB, Kupelian V, Visser M, et al. Strenght, but not muscle mass, is associated with mortality in the Health, Aging and Body Composition Study cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72–77

    PubMed  Google Scholar 

  39. Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159:413–421

    Article  PubMed  Google Scholar 

  40. Visser M, Goodpaster BH, Kritchesvky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci. 2005;60:324–333

    PubMed  Google Scholar 

  41. Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare cost of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–85

    Article  PubMed  Google Scholar 

  42. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995. Report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24–35

    Article  CAS  PubMed  Google Scholar 

  43. Lee JSW, Auyeung TW, Kwok T, et al. Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study. Gerontology. 2007;53:404–410

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gérontopôle, Department of Geriatric Medicine, CHU, Toulouse, F-31059, France

    G. Abellan Van Kan

Authors
  1. G. Abellan Van Kan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abellan Van Kan, G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 13, 708–712 (2009). https://doi.org/10.1007/s12603-009-0201-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-009-0201-z

Keywords

Search

Navigation